A double-edged sword: Interim CEO and corporate social (ir)responsibility activities

被引:0
|
作者
Zheng, Weiwei [1 ]
Lian, Yanling [1 ]
Cui, Xue [1 ]
Sun, Han [1 ]
机构
[1] East China Normal Univ, Sch Econ & Management, 3663 Zhongshan North Rd, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
CSI; CSR; emerging economies; impression management; institutional void; interim CEO; strategic attention; temporal focus; IMPRESSION MANAGEMENT; MEDIA COVERAGE; UPPER ECHELONS; RESPONSIBILITY; SUCCESSION; IRRESPONSIBILITY; PERFORMANCE; IMPACT; CHINA; FOCUS;
D O I
10.1002/csr.2891
中图分类号
F [经济];
学科分类号
02 ;
摘要
Employing an interim CEO is one of the key strategies organizations use to address urgent changes in leadership, yet there is a notable lack of attention in existing corporate governance literature regarding their impact on non-market strategic behaviors. In an effort to bridge this gap, our study integrates institutional theory with impression management literature. Based on unbalanced panel data from Chinese non-state-owned listed companies from 2010 to 2019, the study finds that the succession of an interim CEO is associated with a simultaneous reduction in both corporate social responsibility (CSR) and corporate social irresponsibility (CSI) activities. The negative relationship between interim CEO and CSI activities is weaken in the context of high institutional voids. Mechanism analysis reveals that interim CEOs tend to focus more on the present and allocate more attention toward external stakeholder management strategies and low-cost and efficiency strategies. Additional analysis indicates that in the face of negative financial performance aspirations, interim CEOs are more likely to reduce CSR activities. Similarly, when confronted with negative social performance aspirations, interim CEOs tend to decrease CSI activities to a greater extent.
引用
收藏
页码:5777 / 5800
页数:24
相关论文
共 50 条
  • [31] A Double-Edged Plastic Sword
    Rajeshwar, Krishnan
    ELECTROCHEMICAL SOCIETY INTERFACE, 2018, 27 (02): : 3 - 3
  • [32] AMLODIPINE DOUBLE-EDGED SWORD
    Rabah, Fatma
    Elnour, Ibtisam B.
    El-Naggari, Mohamed
    Al-Nabhani, Dana
    PEDIATRIC NEPHROLOGY, 2015, 30 (09) : 1657 - 1657
  • [33] CpG: The double-edged sword
    Paillard, F
    HUMAN GENE THERAPY, 1999, 10 (13) : 2089 - 2090
  • [34] Calcium: A double-edged sword
    Wetzel, Randall C.
    PEDIATRIC CRITICAL CARE MEDICINE, 2007, 8 (03) : 300 - 301
  • [35] Feedback: a double-edged sword
    不详
    IN PRACTICE, 2014, 36 (09) : 480 - 480
  • [36] Another double-edged sword
    不详
    IEEE SPECTRUM, 2003, 40 (11) : 11 - 11
  • [37] A double-edged sword for NSCLC?
    Alessia Errico
    Nature Reviews Clinical Oncology, 2014, 11 (2) : 66 - 66
  • [38] Morphine - A double-edged sword
    Shavit, Y
    Beilin, B
    PAIN FORUM, 1996, 5 (04): : 237 - 239
  • [39] Prioritization: A Double-Edged Sword?
    Burns, Catherine M.
    Naikar, Neelam
    JOURNAL OF COGNITIVE ENGINEERING AND DECISION MAKING, 2016, 10 (01) : 105 - 108
  • [40] Social exchange in China: The double-edged sword of guanxi
    Warren D.E.
    Dunfee T.W.
    Li N.
    Journal of Business Ethics, 2004, 55 (4) : 355 - 372